Gopal Nikila Devarayasamudram, Krishnamurthy Dinesh
Department of Anaesthesiology, Sri Devaraj Urs Medical College, R L Jalappa Hospital, Kolar, Karnataka, India.
Anesth Essays Res. 2018 Apr-Jun;12(2):528-534. doi: 10.4103/aer.AER_56_18.
Positioning fracture femur cases for sub arachnoid block (SAB) is challenging. Fascia iliaca compartment block (FICB) is low skilled, helps positioning, and provides analgesia. Dexmedetomidine as an adjuvant prolongs analgesia.
The aims were to study and compare FICB with bupivacaine and bupivacaine with dexmedetomidine in fracture femur cases with regard to positioning during SAB, duration of analgesia in terms of Visual Analog Scale (VAS), Numerical Rating Scale (NRS), and Patient Satisfaction Score, and assess side effects.
This was a randomized, double-blind, prospective study.
Sixty fracture femur patients were divided into two groups as follows: Group A: FICB with injection bupivacaine 0.25% 38 cubic centimeter (cc) + dexmedetomidine 0.5 μg/kg in 2 cc normal saline (NS) and Group B: FICB with injection bupivacaine 0.25% 38 cc + 2 cc NS.
Data were analyzed using SPSS 22.0 software. Categorical data were processed by frequencies and proportions, whereas continuous data were processed by mean standard deviation. Chi-square test and independent -test were used as tests of significance, considering < 0.05 as statistically significant.
In Group A, mean VAS score at 5 min (min) was 3.7 ± 0.9 and in Group B it was 4.3 ± 0.7. Similarly, at 15 min, mean VAS score in Group A was 0.4 ± 0.6 and in Group B it was 1.9 ± 0.9. VAS score was significantly high in Group B at 5, 10, and 15 min. Mean time to rescue analgesia in Group A was 838.3 ± 82.7 min and in Group B it was 461.5 ± 36.6 min, which was significant.
FICB ensures patient comfort during positioning for SAB and provides postoperative analgesia. Dexmedetomidine significantly prolongs postoperative analgesia.
为股骨骨折病例进行蛛网膜下腔阻滞(SAB)时的体位摆放具有挑战性。髂筋膜间隙阻滞(FICB)技术要求低,有助于体位摆放,并能提供镇痛效果。右美托咪定作为辅助药物可延长镇痛时间。
本研究旨在比较在股骨骨折病例中,FICB联合布比卡因与布比卡因联合右美托咪定在SAB期间的体位摆放情况、视觉模拟评分法(VAS)、数字评定量表(NRS)及患者满意度评分方面的镇痛持续时间,并评估副作用。
这是一项随机、双盲、前瞻性研究。
60例股骨骨折患者被分为两组,如下:A组:FICB联合0.25% 38立方厘米(cc)布比卡因注射液 + 2 cc生理盐水中的0.5 μg/kg右美托咪定;B组:FICB联合0.25% 38 cc布比卡因注射液 + 2 cc生理盐水。
数据使用SPSS 22.0软件进行分析。分类数据通过频率和比例进行处理,连续数据通过均值标准差进行处理。卡方检验和独立样本t检验用作显著性检验,以P < 0.05为具有统计学显著性。
A组在5分钟(min)时的平均VAS评分为3.7 ± 0.9,B组为4.3 ± 0.7。同样,在15分钟时,A组的平均VAS评分为0.4 ± 0.6,B组为1.9 ± 0.9。在5、10和15分钟时,B组的VAS评分显著更高。A组的平均补救镇痛时间为838.3 ± 82.7分钟,B组为461.5 ± 36.6分钟,差异具有显著性。
FICB可确保SAB体位摆放期间患者的舒适度,并提供术后镇痛。右美托咪定可显著延长术后镇痛时间。